Latest Recruitment News

Amplia Therapeutics has completed recruitment early for its Phase 2a ACCENT trial in advanced pancreatic cancer, reporting encouraging interim results and advancing a second trial with FDA-backed protocol changes.

BauMart Holdings Limited has announced a rights issue to raise approximately $482,000 by offering new shares at a steep discount, aiming to accelerate equipment delivery, fund R&D, and support international recruitment.

BauMart Holdings has unveiled a multi-pronged strategy to tackle construction labour shortages, advance green building materials, and expand mining equipment services, supported by a $482,000 rights issue.

Antipa Minerals has consolidated its Paterson Province tenements into the expansive Minyari Project, resumed full ownership of Wilki and Paterson Projects following partner withdrawals, and launched a major drilling campaign targeting resource growth and new discoveries.

Locality Planning Energy Holdings Ltd (ASX: LPE) reports a cashflow positive nine months to March 2025, confirms no material impact from Cyclone Alfred, and announces key board appointments to support growth.

Paradigm Biopharmaceuticals has secured ethics approval and appointed a CRO to launch its global phase 3 trial for injectable Pentosan Polysulfate Sodium in knee osteoarthritis, while initiating a substantial capital raising program.

Hiremii Limited has completed its 2024-25 AI recruitment platform roadmap nine weeks early, with its proprietary AI outperforming industry shortlisting benchmarks. Despite a slight revenue decline due to market slowdowns, the company is poised for growth through technology commercialization and strategic M&A.

Resonance Health reports record $14.9M cash receipts over 12 months and completes cost-cutting measures while advancing two major pharma clinical trials on schedule.

Race Oncology has opened a second Australian clinical site for its Phase 1 trial of RC220 combined with doxorubicin in advanced solid tumours, aiming to speed patient enrolment and gather critical safety and efficacy data.

DroneShield Limited has reported a record-breaking first quarter with $33.5 million in revenue, more than doubling year-over-year, supported by a robust $94.4 million in committed purchase orders and a burgeoning SaaS segment. The company’s expansive $1.6 billion sales pipeline and strong cash position set the stage for accelerated growth in the counter-unmanned systems market.

TruScreen has launched a landmark five-year cervical cancer screening program in Ho Chi Minh City, targeting 260,000 women with its AI-driven, non-invasive technology to boost screening rates and support Vietnam’s national health goals.

IGNITE Limited reports a striking 189% jump in statutory profit for H1 FY25, even as revenue slips 7%, underscoring a successful turnaround strategy and a strong balance sheet.